低风险前列腺癌主动监测在美国人口普查区域使用差异数据表2
基于SEER数据，分析2010至2016年美国各人口普查区域低风险前列腺癌主动监测使用差异的研究补充数据表。
基本信息
资源简介
低风险前列腺癌主动监测在美国人口普查区域使用差异数据表2
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集，收录 1 个文件、合计 44.63 KB，主题涵盖 low-risk prostate cancer、active surveillance、geographic variation、watchful waiting、radical prostatectomy，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Data_Sheet_2_Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.pdf》。配套论文《Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015》发表于 JAMA（2019），DOI：10.1001/jama.2018.19941。源站首次发布：2021-05-19。
【数据内容】
源站原始描述：Substantial geographic variation in healthcare practices exist. Active surveillance (AS) has emerged as a critical tool in the management of men with low-risk prostate cancer. Whether there have been regional differences in adoption is largely unknown. The SEER “Prostate with Watchful Waiting Database” was used to identify patients diagnosed with localized low-risk prostate cancer and managed with AS across US census regions between 2010 and 2016. Multivariable logistic regression models were us…
中文译文（机器翻译，仅供快速理解，请以原文为准）：医疗实践存在显著的地域差异。主动监测（AS）已成为低危前列腺癌男性患者管理的重要工具。然而，各地区在采用这一方法上是否存在差异，目前尚不明确。本研究利用SEER“前列腺观察等待数据库”，识别2010年至2016年间美国各人口普查区域内诊断为局限性低危前列腺癌并接受AS管理的患者。采用多因素logistic回归模型，确定地域对接受AS的影响以及各人口普查区域内与AS使用相关的因素。2010年至2016年间，接受AS管理的男性比例在西部从20.8%上升至55.9%，东北部从11.5%上升至50.0%，南部从9.9%上升至43.4%，中西部从15.1%上升至56.2%（p < 0.0001）。多因素分析显示，与西部相比，所有其他地区的男性接受AS的可能性均较低（p < 0.001）。西部（OR 1.36，95%CI 1.25–1.49）和中西部（OR 1.62，95%CI 1.35–1.95）的黑人男性更可能接受AS，但在东北部则较不可能接受（OR 0.80，95%CI 0.69–0.92）。社会经济地位（SES）较高的男性在西部（OR 1.47，95%CI 1.39–1.55）、东北部（OR 1.57，95%CI 1.36–1.81）和南部（OR 1.24，95%CI 1.13–1.37）更可能接受AS，但在中西部则不然（OR 0.85，95%CI 0.73–0.98）。我们发现，AS的采用率因种族和SES而存在显著的地域差异。在评估AS使用的障碍时，必须将地理因素纳入考量。
【数据结构与技术规格】
文件数 1 个，合计 44.63 KB。Data_Sheet_2_Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.pdf：application/pdf，44.63 KB。数据集 DOI：10.3389/fonc.2021.644885.s002。
【主题与分类】
源站学科分类：Cancer、Haematological Tumours、Radiation Therapy、Solid Tumours、Oncology and Carcinogenesis not elsewhere classified、Molecular Targets。主题标签：low-risk prostate cancer、active surveillance、geographic variation、watchful waiting、radical prostatectomy、radiation therapy。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_2_Variation_in_the_Use_of_Active_Surveillance_for_Low-Risk_Prostate_Cancer_Across_US_Census_Regions_pdf/14615913
使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。
规范引用：Awamlh, Bashir Al Hussein Al; Patel, Neal; Ma, Xiaoyue; Calaway, Adam; Ponsky, Lee; Hu, Jim C.; et al. (2021). Data_Sheet_2_Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.pdf. Frontiers. Dataset
【使用注意】
· 源站最后修改于 2023-06-01，引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务（收技术服务费，非数据销售）
暂未开放当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：Data_Sheet_2_Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.pdf
- DOI：10.3389/fonc.2021.644885.s002
- 发布日期：2021-05-19
- 文件数：1 个
- 文件总体积：44.63 KB
- 源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_2_Variation_in_the_Use_of_Active_Surveillance_for_Low-Risk_Prostate_Cancer_Across_US_Census_Regions_pdf/14615913
命令行下载
curl -L -o "Data_Sheet_2_Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.pdf" "https://ndownloader.figshare.com/files/28064232"
文件清单
Data_Sheet_2_Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.pdf（44.63 KB）
文件总体积 44.63 KB（源站 API 实测）。
数据加载示例（图像类）
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Substantial geographic variation in healthcare practices exist. Active surveillance (AS) has emerged as a critical tool in the management of men with low-risk prostate cancer. Whether there have been regional differences in adoption is largely unknown. The SEER “Prostate with Watchful Waiting Database” was used to identify patients diagnosed with localized low-risk prostate cancer and managed with AS across US census regions between 2010 and 2016. Multivariable logistic regression models were used to determine the impact of region on undergoing AS and factors associated with AS use within each US census region. Between 2010 and 2016, the proportion of men managed with AS increased from 20.8% to 55.9% in the West, 11.5% to 50.0% in Northeast, 9.9% to 43.4% in the South and 15.1% to 56.2% in Midwest (p < 0.0001). On multivariable analysis, as compared to the West, men in all regions were less likely to undergo AS (p < 0.001). Black men in the West (OR 1.36, 95%CI 1.25–1.49) and Midwest (OR 1.62, 95%CI 1.35–1.95) were more likely to undergo AS, but less likely in Northeast (OR 0.80, 95%CI 0.69–0.92). Men with higher socioeconomic status (SES) were more likely to undergo AS in the West (OR 1.47, 95%CI 1.39–1.55), Northeast (OR 1.57, 95%CI 1.36–1.81), and South (OR 1.24, 95%CI 1.13–1.37) but not in the Midwest (OR 0.85, 95%CI 0.73–0.98). We found striking regional differences in the uptake of AS according to race and SES. Geography must be taken into consideration when assessing barriers to AS use.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fonc.2021.644885.s002（source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_2_Variation_in_the_Use_of_Active_Surveillance_for_Low-Risk_Prostate_Cancer_Across_US_Census_Regions_pdf/14615913）。
数据缺失？
依托陕西、四川两大基地，我们与超过十家三甲医院建立直接合作关系，覆盖合规授权、采集治理、专业标注、数据交付的全流程，为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务？立即联系我们获取专业方案。
